ReviewThoracic cancer2020

The role of IL-6 in immunotherapy of non-small cell lung cancer (NSCLC) with immune-related adverse events (irAEs).

Wanhai Ke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.